Tengfei Zhang
7 Luoxuan 4th Road
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Afatinib for patients with non-small-cell lung cancer harboring major EGFR G719X + S768I co-mutations: a retrospective, observation study in Xuanwei and Fuyuan, China.
Journal: Chinese clinical oncology
Published: April 20, 2025
Induction chemotherapy followed by radiotherapy in primary small cell neuroendocrine carcinoma of the parotid gland: a case report and literature review.
Journal: Chinese clinical oncology
Published: November 30, 2024
Changes in pulmonary function of CT-guided microwave ablation for patients with pulmonary ground-glass nodules after lobectomy: a retrospective, observation study.
Journal: Discover oncology
Published: September 15, 2024
Safety and Efficacy of CT-Guided Central Venous Catheter Gastric Insufflation in Percutaneous Gastrostomy.
Journal: BioMed research international
Published: July 22, 2022
Efficacy, safety and prognostic factors of camrelizumab plus carboplatin and pemetrexed chemotherapy in advanced lung adenocarcinoma patients.
Journal: Journal of clinical pharmacy and therapeutics
Published: February 28, 2022
Durable Clinical Response of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in trans-C797S to Combination Therapy of First- and Third-Generation EGFR Tyrosine Kinase Inhibitors.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 16, 2019
Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib.
Journal: Targeted oncology
Published: March 22, 2019
Characterization of acquired receptor tyrosine-kinase fusions as mechanisms of resistance to EGFR tyrosine-kinase inhibitors.
Journal: Cancer management and research
Published: December 06, 2018
A combined subtype of small cell lung cancer and adenocarcinoma with epidermal growth factor receptor (EGFR) mutation responds to EGFR tyrosine kinase inhibitors.
Journal: Journal of thoracic disease
Published: December 04, 2018
Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients.
Journal: Drug design, development and therapy
Published: November 27, 2018
Clinical characterization of ERBB2 exon 20 insertions and heterogeneity of outcomes responding to afatinib in Chinese lung cancer patients.
Journal: OncoTargets and therapy
Published: November 15, 2018
Last Updated: 09/26/2026